Atheroembolic renal disease: A silent masquerader

Kidney International

Volumn 73, Issue 1, 2008, Pages 126-130

  Mittal, B V ^a   Alexander, M P ^a   Rennke, H G ^a   Singh, A K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATORVASTATIN; CREATININE; ENALAPRIL;

AGED; ANAMNESIS; ARTICLE; ATHEROEMBOLIC RENAL DISEASE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; TISSUE SECTION; UREMIA;

EID: 37249085791     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002433     Document Type: Article

References (30)

1. Flory CM. Arterial occlusion produced by emboli from eroded aortic atheromatous plaques. Am J Pathol 1945; 21: 549-565.
2. Scolari F, Tardanico R, Pola A et al. Cholesterol crystal embolic disease in renal allografts. J Nephrol 2003; 16: 139-143.
3. Kealy W. Atheroembolism. J Clin Pathol 1978; 31: 984-989.
4. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. New Engl J Med 1957; 257: 442-447.
5. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med 1996; 100: 524-529.
6. Peat DS, Mathieson PW. Cholesterol emboli may mimic systemic vasculitis. Br Med J 1996; 313: 546-547.
7. Aviles B, Ubeda I, Blanco J et al. Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Am J Kidney Dis 2002; 40: 847-851.
8. Scolari F, Tardanico R, Zani R et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000; 36: 1089-1109.
9. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery 1989; 105: 737-746.
10. Fine MJ, Kapoor W, Falanga V. Crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 38: 769-784.
11. Scolari F, Ravani P, Pola A et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003; 14: 1584-1590.
12. Hara S, Asada Y, Fujimoto S et al. Atheroembolic renal disease: clinical findings of 11 cases. J Atheroscler Thromb 2002; 9: 288-291.
13. Greenberg A, Bastacky SI, Iqbal A et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 1997; 29: 334-344.
14. Saklayen M. Atheroembolic renal disease: preferential occurrence in whites only. Am J Nephrol 1989; 9: 87-88.
15. Cross SS. How common is cholesterol embolism? J Clin Pathol 1991; 44: 859-861.
16. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999; 33: 840-850.
17. Colt HG, Begg RJ, Saporito JJ et al. Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine (Baltimore) 1988; 67: 389-400.
18. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 1986; 122: 1194-1198.
19. Lin PH, Bush RL, Conklin BS et al. Late complication of aortoiliac stent placement atheroembolization of the lower extremities. J Surg Res 2002; 103: 153-159.
20. Schonermarck U, Guba M, Weiss M et al. Cholesterol atheroembolic disease in kidney allografts-case report and review of the literature. Clin Nephrol 2006; 66: 386-390.
21. Kaplan-Pavlovcic S, Vizjak A, Vene N et al. Antineutrophil cytoplasmic autoantibodies in atheroembolic disease. Nephrol Dial Transplant 1998; 13: 985-987.
22. Espejo B, Herrero JC, Torres A et al. Immunoallergic interstitial nephritis vs. cholesterol atheroembolism. Differentiating characteristics. Nefrologia 2003; 23: 125-130.
23. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 2006; 69: 1308-1312.
24. Zuccala A, Zucchelli P. A renal disease frequently found at postmortem, but rarely diagnosed in vivo. Nephrol Dial Transplant 1997; 12: 1762-1767.
25. Theriault J, Agharazzi M, Dumont M et al. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 2003; 94: c11-c18.
26. Sanai T, Matsui R, Hirano T. LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery - a case report. Angiology 2006; 57: 379-382.
27. Nakayama M, Nagata M, Hirano T et al. Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism. Clin Nephrol 2006; 66: 232-239.
28. Kryvoshey D, Kammerl M, Hoffmann U et al. Cholesterol crystal embolism: diagnostic and treatment. Kidney Int 2006; 70: 1525.
29. Martin-Ventura JL, Blanco-Colio LM, Gomez-Hernandez A et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke 2005; 36: 1796-1800.
30. Belenfant X. Cholesterol crystal embolism disease, diagnostic criteria. Presse Med 2002; 31: 1271-1276.